Over the years, we have cultivated a group of advisors with expertise in biotechnology, pharmacology, metabolic engineering, and enzymology. We need to build a cadre of advisors and partners who work directly with sickle cell therapeutic solutions and sickle cell anemia patients to know, first-hand, what the challenges and needs are.